Vésale Bioscience Nommée Start-Up La Plus Innovante D’Europe En Sciences De La Vie Lors De La 10e Édition De BioFIT
La Libre
Vésale Bioscience lève une première tranche de 3 millions d’euros : en préparation de son IPO, avancée à fin 2022, Vésale Bioscience récolte une première levée de fonds auprès d’investisseurs privés.
Lpost
Renfort de poids pour Vésale Bioscience : les dirigeants de Vésale Bioscience ont engagé Guillaume de Viron comme directeur financier (CFO) de la société de recherche et développement.
L’Écho
Vésale Bioscience raises a first tranche of €3 million: in preparation for its IPO, which has been brought forward to the end of 2022, Vésale Bioscience has raised a first tranche of funds from private investors.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
